CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 
 

MRNA's Capital Expenditures Growth by Quarter and Year

Moderna Inc 's Capital Expenditures results by quarter and year




MRNA Capital Expenditures (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 23.30 - 0.05
III Quarter September - 19.29 - 0.03
II Quarter June 30.00 18.63 -0.01 0.01
I Quarter March 35.00 6.22 - -
FY   65.00 67.44 -0.01 0.09



MRNA Capital Expenditures second quarter 2021 Y/Y Growth Comment
Moderna Inc achieved in the second quarter, above Company average Capital Expenditures rise of 61.03% year on year, to $ 30.00 millions.

Looking into second quarter results within Biotechnology & Pharmaceuticals industry 63 other companies have achieved higher Capital Expenditures growth. While Moderna Inc ' s Capital Expenditures jump of 61.03% ranks overall at the positon no. 1056 in the second quarter.




MRNA Capital Expenditures ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -62.5 %
II Quarter June 61.03 % - - -96.67 %
I Quarter March 462.7 % - - -
FY   - - - -76.32 %

Financial Statements
Moderna Inc 's second quarter 2021 Capital Expenditures $ 30.00 millions MRNA's Income Statement
Moderna Inc 's second quarter 2020 Capital Expenditures $ 18.63 millions Quarterly MRNA's Income Statement
New: More MRNA's historic Capital Expenditures Growth >>


MRNA Capital Expenditures (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 20.79 % - 66.67 %
III Quarter September - 3.54 % - 200 %
II Quarter June -14.29 % 199.52 % - -
I Quarter March 50.21 % - - -
FY (Year on Year)   - - - -76.32 %




Capital Expenditures second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #64
Healthcare Sector #242
Overall #1056

Capital Expenditures Y/Y Growth Statistics
High Average Low
462.43 % -14.96 % -100 %
(Mar 31 2021)   (Dec 31 2019)
Capital Expenditures second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #64
Healthcare Sector #242
Overall #1056
Capital Expenditures Y/Y Growth Statistics
High Average Low
462.43 % -14.96 % -100 %
(Mar 31 2021)   (Dec 31 2019)

Capital Expenditures by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Moderna Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
199.41 % 10.64 % -100 %
(Jun 30 2020)  


MRNA's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2021 Moderna Inc realized drop in Capital Expenditures sequentially by -14.29% to $ 30.00 millions, from $ 35.00 millions released in the previous reporting period.

Even periodic circumstance were not able to recover the II. Quarter for the Moderna Inc , Isak Bengtsson, market researcher from Dubai said, he mentioned some skepticism towards Moderna Inc 's direction, he identified new difficulties down the road for Moderna Inc and wrote that average quarter on quarter Capital Expenditures growth is at 10.64% for Moderna Inc .

Within Biotechnology & Pharmaceuticals industry 94 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Moderna Inc 's Capital Expenditures growth quarter on quarter, overall rank is 2539.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #95
Healthcare Sector #444
Overall #2539
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #95
Healthcare Sector #444
Overall #2539
Capital Expenditures Q/Q Growth Statistics
High Average Low
199.41 % 10.64 % -100 %
(Jun 30 2020)  


MRNA's II. Quarter Q/Q Capital Expenditures Comment
In the II. Quarter 2021 Moderna Inc reported drop in Capital Expenditures from the first quarter by -14.29% to $ 30.00 millions, from $ 35.00 millions released a quarter before.

Those periodic circumstance which commonly elevate II. Quarter 2021 results, were not able to rescue the II. Quarter for the Moderna Inc , Isak Bengtsson, market researcher from Dubai wrote, he mentioned some caution towards MRNA's perspective and wrote that average quarter on quarter Capital Expenditures growth is at 10.64% for MRNA.

Within Biotechnology & Pharmaceuticals industry 94 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Moderna Inc 's Capital Expenditures growth quarter on quarter, overall rank is 2539.


Moderna Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
Cumulative Capital Expenditures 12 Months Ending $ 107.59 $ 96.23 $ 67.45 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) 11.81 % 42.67 % - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 834 # 261 # 263 # 0 # 0




Cumulative Capital Expenditures growth Comment
Moderna Inc saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 61.03% year on year, to $ 108 millions if the fiscal year would have ended in Jun 30 2021.
Moderna Inc 's trailing twelve months Capital Expenditures growth was higher than company's average 0% and higher than % growth in Mar 31 2021. And, Moderna Inc realized the fastest Capital Expenditures growth, in Biotechnology & Pharmaceuticals industry.
But from twelve months ended Mar 31 2021 rise was slower at 11.81 % from $96.23 millions achieved in twelve months ending a quarter Mar 31 2021.
There is drop-off in progress, more obvious if you pay attention to the typical Q/Q TTM historic rise what is better at27.24% Isak Bengtsson wrote.

Moderna Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
42.67 %
27.24 %
11.81 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 50
Sector # 192
S&P 500 # 834
Cumulative Capital Expenditures growth Comment
Moderna Inc saw improvement in Capital Expenditures growth trend, posting cumulative 12 months Capital Expenditures growth of 61.03% year on year, to $ 108 millions if the fiscal year would have ended in Jun 30 2021.
Moderna Inc 's trailing twelve months Capital Expenditures growth was higher than company's average 0% and higher than % growth in Mar 31 2021. And, Moderna Inc realized the fastest Capital Expenditures growth, in Biotechnology & Pharmaceuticals industry.
But from the previous reporting period rise was less at 11.81 % from $96.23 millions reported in the period from Mar 31 2021 to Jun 30 2020.
There is stagnation developing, more noticeable observing the typical Q/Q TTM historic rise which is higher at 27.24% Isak Bengtsson noted.
The momentum is even higher from the previous reporting period clinched at 11.81 % jump from $96.23 millions in the period from Mar 31 2021 to Jun 30 2020.

Moderna Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
42.67 %
27.24 %
11.81 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 50
Sector # 192
S&P 500 # 834




Other Capital Expenditures Growth
Biotechnology & Pharmaceuticals Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
MRNA's Capital Expenditures Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for MRNA's Competitors
Capital Expenditures Growth for Moderna Inc 's Suppliers
Capital Expenditures Growth for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Dividend Payout Ratio
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Jun 30 2021 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Jun 30 2021
Luna Innovations Inc105.07%$ 105.072 millions
Krystal Biotech Inc 104.98%$ 104.985 millions
Immunogen inc 104.35%$ 104.348 millions
Agenus Inc103.04%$ 103.041 millions
Inogen Inc 102.16%$ 102.160 millions
Organogenesis Holdings Inc 99.86%$ 99.862 millions
Cytosorbents Corporation97.98%$ 97.982 millions
Guardant Health Inc 96.43%$ 96.434 millions
Invitae Corp95.40%$ 95.401 millions
Iovance Biotherapeutics inc 93.29%$ 93.286 millions
Delcath Systems Inc 92.68%$ 92.683 millions
Nature s Sunshine Products inc 91.31%$ 91.309 millions
Meiragtx Holdings Plc91.19%$ 91.186 millions
Emergent Biosolutions Inc 90.88%$ 90.883 millions
Electromed Inc 89.08%$ 89.080 millions
Durect Corp88.89%$ 88.889 millions
Synlogic Inc 88.89%$ 88.889 millions
Precision Optics Corporation Inc 88.61%$ 88.613 millions
Owens and Minor Inc 87.56%$ 87.556 millions
Myriad Genetics Inc 87.50%$ 87.500 millions
National Research Corporation87.22%$ 87.216 millions
Sientra inc 86.96%$ 86.957 millions
Insmed Inc85.27%$ 85.274 millions
Arrowhead Pharmaceuticals Inc 83.84%$ 83.841 millions
Cue Biopharma Inc 78.72%$ 78.723 millions
T2 Biosystems Inc 76.67%$ 76.667 millions
Dexcom Inc 73.88%$ 73.883 millions
Avantor Inc 73.33%$ 73.333 millions
Reynolds Consumer Products Inc 72.41%$ 72.414 millions
Revance Therapeutics Inc 70.73%$ 70.732 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CCEL's Profile

Stock Price

CCEL's Financials

Business Description

Fundamentals

Charts & Quotes

CCEL's News

Suppliers

CCEL's Competitors

Customers & Markets

Economic Indicators

CCEL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071